Literature DB >> 23179836

Human long-term culture initiating cell assay.

Min Liu1, Cindy L Miller, Connie J Eaves.   

Abstract

The long-term culture initiating cell (LTC-IC) assay, founded on the bone marrow long-term culture (LTC) system, measures primitive hematopoietic stem cells (termed LTC-IC) based on their capacity to produce myeloid progeny for at least 5 weeks. Adaptations of the LTC system including the use of stromal cell lines, application of limiting dilution analysis, and estimation of average hematopoietic progenitor output per LTC-IC under defined conditions have made it possible to accurately determine LTC-IC content in minimally separated and highly purified cell populations from human hematopoietic tissue sources such as bone marrow, peripheral blood, cord blood, fetal liver as well as cord blood and mobilized peripheral blood. Methodologies for measuring human LTC-IC using bulk cultures, limiting dilution analysis, and single cell cultures are described.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23179836     DOI: 10.1007/978-1-62703-128-8_15

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  11 in total

1.  Clonogenic cell subpopulations maintain congenital melanocytic nevi.

Authors:  Christelle Charbel; Romain H Fontaine; Natacha Kadlub; Aurore Coulomb-L'Hermine; Thomas Rouillé; Alexandre How-Kit; Philippe Moguelet; Jorg Tost; Arnaud Picard; Selim Aractingi; Sarah Guégan
Journal:  J Invest Dermatol       Date:  2014-10-13       Impact factor: 8.551

2.  The Master Regulator Protein BAZ2B Can Reprogram Human Hematopoietic Lineage-Committed Progenitors into a Multipotent State.

Authors:  Karthik Arumugam; William Shin; Valentina Schiavone; Lukas Vlahos; Xiaochuan Tu; Davide Carnevali; Jordan Kesner; Evan O Paull; Neus Romo; Prem Subramaniam; Jeremy Worley; Xiangtian Tan; Andrea Califano; Maria Pia Cosma
Journal:  Cell Rep       Date:  2020-12-08       Impact factor: 9.423

3.  NFĸB Targeting in Bone Marrow Mesenchymal Stem Cell-Mediated Support of Age-Linked Hematological Malignancies.

Authors:  Lauren S Sherman; Shyam A Patel; Marianne D Castillo; Rachel Unkovic; Marcelo Taborga; Marina Gergues; Shaun Patterson; Jean-Pierre Etchegaray; Mohammed Jaloudi; Anupama Hooda-Nehra; Joshua Kra; Darling P Rojas; Victor T Chang; Pranela Rameshwar
Journal:  Stem Cell Rev Rep       Date:  2021-08-19       Impact factor: 5.739

4.  PP2A is a therapeutically targetable driver of cell fate decisions via a c-Myc/p21 axis in human and murine acute myeloid leukemia.

Authors:  Swagata Goswami; Rajeswaran Mani; Jessica Nunes; Chi-Ling Chiang; Kevan Zapolnik; Eileen Hu; Frank Frissora; Xiaokui Mo; Logan A Walker; Pearlly Yan; Ralf Bundschuh; Larry Beaver; Raymond Devine; Yo-Ting Tsai; Ann Ventura; Zhiliang Xie; Min Chen; Rosa Lapalombella; Alison Walker; Alice Mims; Karilyn Larkin; Nicole Grieselhuber; Chad Bennett; Mitch Phelps; Erin Hertlein; Gregory Behbehani; Sumithira Vasu; John C Byrd; Natarajan Muthusamy
Journal:  Blood       Date:  2022-03-03       Impact factor: 25.476

5.  Functional assessment of hematopoietic niche cells derived from human embryonic stem cells.

Authors:  Patrick I Ferrell; Melinda K Hexum; Ross A Kopher; Michael A Lepley; Amanda Gussiaas; Dan S Kaufman
Journal:  Stem Cells Dev       Date:  2014-03-11       Impact factor: 3.272

6.  Heterogeneous Niche Activity of Ex-Vivo Expanded MSCs as Factor for Variable Outcomes in Hematopoietic Recovery.

Authors:  Jung-Ho Kim; Ho-Sun Lee; Hyun-Kyung Choi; Jin-A Kim; In-Sun Chu; Sun-Hee Leem; Il-Hoan Oh
Journal:  PLoS One       Date:  2016-12-28       Impact factor: 3.240

7.  Chronic lymphocytic leukemia B-cell-derived TNFα impairs bone marrow myelopoiesis.

Authors:  Bryce A Manso; Jordan E Krull; Kimberly A Gwin; Petra K Lothert; Baustin M Welch; Anne J Novak; Sameer A Parikh; Neil E Kay; Kay L Medina
Journal:  iScience       Date:  2020-12-26

8.  Establishment of a Long-Term Co-culture Assay for Mesenchymal Stromal Cells and Hematopoietic Stem/Progenitors.

Authors:  Sayantani Sinha; Sayan Chakraborty; Amitava Sengupta
Journal:  STAR Protoc       Date:  2020-11-24

9.  Combined Inhibition of Bcl2 and Bcr-Abl1 Exercises Anti-Leukemia Activity but Does Not Eradicate the Primitive Leukemic Cells.

Authors:  Michele Massimino; Paolo Vigneri; Stefania Stella; Elena Tirrò; Maria Stella Pennisi; Laura Nunziatina Parrinello; Calogero Vetro; Livia Manzella; Fabio Stagno; Francesco Di Raimondo
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

10.  Real-time monitoring and control of soluble signaling factors enables enhanced progenitor cell outputs from human cord blood stem cell cultures.

Authors:  Elizabeth Csaszar; Kun Chen; Julia Caldwell; Warren Chan; Peter W Zandstra
Journal:  Biotechnol Bioeng       Date:  2013-12-16       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.